Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Actinium Pharmaceuticals, Inc. has filed 494 SEC EDGAR filings since 05 Feb 2007

SEC filing history

Showing 51-75 of 468 matching filings.

Per page
25
Current page
3
8-K File 001-36374

CURRENT REPORT

Filing date
01 Dec 2023
Reporting date
30 Nov 2023
Next action
Verify source filing
ARS File 001-36374

FORM ARS

Filing date
09 Nov 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36374

PROXY STATEMENT

Filing date
09 Nov 2023
Reporting date
30 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
02 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
UPLOAD File 333-273911

UPLOAD filing

Filing date
17 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
S-3 File 333-273911

REGISTRATION STATEMENT

Filing date
11 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
15 May 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
10-K File 001-36374

ANNUAL REPORT

Filing date
31 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
10 Mar 2023
Reporting date
10 Mar 2023
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
21 Feb 2023
Reporting date
18 Feb 2023
Next action
Verify source filing
SC 13G/A File 005-82467

SC 13G/A filing

Filing date
06 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
30 Dec 2022
Reporting date
30 Dec 2022
Next action
Verify source filing
DEFA14A File 001-36374

DEFINITIVE ADDITIONAL MATERIALS

Filing date
09 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
09 Dec 2022
Reporting date
08 Dec 2022
Next action
Verify source filing
DEF 14A File 001-36374

PROCY STATEMENT

Filing date
21 Nov 2022
Reporting date
08 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
31 Oct 2022
Reporting date
31 Oct 2022
Next action
Verify source filing
S-8 File 333-266996

REGISTRATION STATEMENT

Filing date
19 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Aug 2022
Reporting date
17 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
12 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .